Article
Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4.
American journal of nephrology - 1 Jan 2017
Abad Soraya, Vega Almudena, Hernández Eduardo, Mérida Evangelina, de Sequera Patricia, Albalate Marta, Macías Nicolás, Milla Monica, López-Gómez Juan M
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) infection is highly prevalent among patients on hemodialysis (HD) and is associated with poor prognosis. Treatment with interferon and ribavirin is poorly tolerated, and few data are available on the impact of new direct-acting antivirals (DAAs). This study was intended to analyze the efficacy and safety of treatment with a combination of ombitasvir/paritaprevir/ritonavir and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.